Drinking two to three cups of coffee a day is linked with a longer lifespan and lower risk of cardiovascular disease compared with avoiding coffee, according to research published today in the European Journal of Preventive ...
Sep 26, 2022
0
204
A nationwide study in France has reported that during the 2019 heatwave, hot temperatures were closely linked with weight loss in heart failure patients, indicating worsening of their condition. The study is published today ...
Sep 21, 2022
0
17
Obese women who use oral contraceptives containing estrogen and progestin have a 24-fold increased risk of venous thromboembolism (VTE) compared with non-obese women not using the drugs, according to a review paper published ...
Sep 15, 2022
1
6
A randomized trial in nearly 4,000 outpatients with COVID-19 has found no benefit of treatment with aspirin or colchicine. The late breaking research was presented in a Hot Line session on 29 August at ESC Congress 2022.
Aug 30, 2022
0
13
Routinely-collected health care data has the potential to improve the lives and well-being of patients across the world, through better understanding of disease, and research on existing and new treatments. Presented today ...
Aug 30, 2022
0
40
Radial artery access for coronary angiography or percutaneous coronary intervention (PCI) is associated with lower risks of all-cause death and bleeding compared with femoral access. That's the finding of late breaking research ...
Aug 30, 2022
0
2
A non-invasive imaging technique for detecting coronary artery disease activity in patients with myocardial infarction did not predict the primary endpoint of all coronary events but did predict all-cause mortality and cardiac ...
Aug 29, 2022
0
4
A phase 2 trial in patients with a prior ischemic stroke or high-risk transient ischemic attack (TIA) has indicated that milvexian should be further investigated for its ability to reduce the risk of ischemic stroke without ...
Aug 29, 2022
0
14
The PACIFIC-Stroke trial has failed to reach its primary endpoint but in an exploratory analysis, inhibition of factor XIa with asundexian reduced recurrent ischemic stroke and transient ischemic attack (TIA) without increasing ...
Aug 29, 2022
0
4
Asundexian 50 mg administered to post-myocardial infarction patients inhibits factor XIa by more than 90% with no significant increase in bleeding, according to late breaking research presented in a Hot Line session on 28 ...
Aug 29, 2022
0
4
